Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Asieris, Biogen, Biontech, Diffusion, Eisai, Enzychem Lifesciences, Fujifilm Kyowa Kirin, Immodulon, Merck, Mylan, Novartis, Otsuka, Pfizer, Propeller Health, Senhwa, Sosei.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avicenna.AI, Corneat Vision, Dante Labs, GI Supply, Hd Medical, Qubyx, Revamp Medical, Vela Diagnostics, Vitls, Viveve.